VISINE RED EYE HYDRATING COMFORT  EYE DROPS- tetrahydrozoline hydrochloride and polyethylene glycol 400 solution/ drops 
Johnson & Johnson Consumer Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

VISINE ® Red Eye Hydrating Comfort

Drug Facts

Active ingredientsPurpose
Polyethylene glycol 400 1%Lubricant
Tetrahydrozoline HCl 0.05%Redness reliever

Uses

Warnings

For external use only

Ask a doctor before use if you have narrow angle glaucoma.

When using this product

  • pupils may become enlarged temporarily
  • overuse may cause more eye redness
  • remove contact lenses before using
  • do not use if this solution changes color or becomes cloudy
  • do not touch tip of container to any surface to avoid contamination
  • replace cap after each use

Stop use and ask a doctor if

  • you feel eye pain
  • changes in vision occur
  • redness or irritation of the eye lasts
  • condition worsens or lasts more than 72 hours

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Store at 20° to 25°C (68° to 77°F)

Inactive ingredients

ascorbic acid, boric acid, dextrose, glycerin, glycine, hypromellose, magnesium chloride, polyquaternium-42, potassium chloride, purified water, sodium citrate, sodium lactate, sodium phosphate dibasic

Questions?

call toll-free 888-734-7648 or 215-273-8755 (collect)

Distributed by: JOHNSON & JOHNSON CONSUMER INC. Skillman, NJ 08558

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton

VISINE ®
RED EYE
HYDRATING
COMFORT

LUBRICANT/REDNESS RELIEVER EYE DROPS

WORKS IN 30 SECONDS
Redness + Irritation Relief

Lubricates +
Refreshes
STERILE
1/2 FL OZ (15mL)

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton
VISINE RED EYE HYDRATING COMFORT   EYE DROPS
tetrahydrozoline hydrochloride and polyethylene glycol 400 solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69968-0356
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TETRAHYDROZOLINE HYDROCHLORIDE (UNII: 0YZT43HS7D) (TETRAHYDROZOLINE - UNII:S9U025Y077) TETRAHYDROZOLINE HYDROCHLORIDE0.5 mg  in 1 mL
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) (POLYETHYLENE GLYCOL 400 - UNII:B697894SGQ) POLYETHYLENE GLYCOL 40010 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ASCORBIC ACID (UNII: PQ6CK8PD0R)  
BORIC ACID (UNII: R57ZHV85D4)  
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
GLYCERIN (UNII: PDC6A3C0OX)  
GLYCINE (UNII: TE7660XO1C)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)  
POLIXETONIUM CHLORIDE (UNII: RNW5AM67C0)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
WATER (UNII: 059QF0KO0R)  
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
SODIUM LACTATE (UNII: TU7HW0W0QT)  
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69968-0356-21 in 1 CARTON04/27/2020
115 mL in 1 BOTTLE, DROPPER; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug
2NDC:69968-0356-1700 in 1 CONTAINER, FLEXIBLE INTERMEDIATE BULK04/27/2020
28 mL in 1 BOTTLE, DROPPER; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug
3NDC:69968-0356-31 in 1 CARTON04/27/2020
38 mL in 1 BOTTLE, DROPPER; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug
4NDC:69968-0356-41 in 1 BLISTER PACK04/27/2020
48 mL in 1 BOTTLE, DROPPER; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34904/27/2020
Labeler - Johnson & Johnson Consumer Inc. (118772437)

Revised: 1/2023
Document Id: ee83fbf4-ce99-eb42-e053-2995a90aa4ff
Set id: a9a90de6-3172-4d34-984b-f4442f880e3d
Version: 3
Effective Time: 20230103
 
Johnson & Johnson Consumer Inc.